Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Public Health|April 2, 2025
Burden of acute and long-term COVID-19: a nationwide study in BahrainMariam Murad, Stephen L Atkin, Pearl Wasif, et al.
Gastroenterology|July 4, 2018
Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel BleedingMoe H Kyaw, Koji Otani, Jessica Y L Ching, et al.
Pulmonary Therapy|October 6, 2025
A Retrospective Observational Study on COVID-19 Patients Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID)Mariam M Murad, Stephen L Atkin, Pearl W Wasif, et al.
Journal of Diabetes Investigation|January 30, 2023
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE studyDae Jung Kim, Wayne H-H Sheu, Wook-Jin Chung, et al.
BMC Infectious Diseases|February 8, 2025
Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort studyAltynay Shigayeva, Christopher Kandel, Lubna Farooqi, et al.
Influenza and Other Respiratory Viruses|January 13, 2026
Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario CanadaCaroline Kassee, Altynay Shigayeva, Christopher Kandel, et al.
Journal of Gastroenterology and Hepatology|July 1, 2020
Endoscopic ultrasound-guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhageRaymond S Y Tang, Moe H Kyaw, Anthony Y B Teoh, et al.
Journal of Diabetes Investigation|December 3, 2021
Healthcare resource utilization in patients treated with empagliflozin in East AsiaWayne H-H Sheu, Yutaka Seino, Elise Chia-Hui Tan, et al.
Endocrinology, Diabetes & Metabolism|February 3, 2021
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia studyYutaka Seino, Dae Jung Kim, Daisuke Yabe, et al.
Pageof 13